Stock listing
Huons Global Co., Ltd.
Selected listing: 084110 · KRX · KRW · KR
Huons Global Co., Ltd. (KRX:084110), Health Technology. Latest release Jul 23, 2025: Huonslab Secures Formulation Patent for Recombinant Human Hyaluronidase…
- Ticker
- KRX:084110
- Asset type
- Stock
- Sector
- Health Technology
- Industry
- Pharmaceuticals: Major
- Exchange
- KRX
- Currency
- KRW
About Huons Global Co., Ltd.
The company operates in the healthcare sector, focusing on innovative products and solutions. Huons Global is committed to enhancing the quality of life through its diverse offerings in pharmaceuticals and medical devices.
Latest news from Huons Global Co., Ltd.
Huonslab Secures Formulation Patent for Recombinant Human Hyaluronidase Product, HYDIZYME™
July 23, 2025
Huonslab Achieves Last-Patient-In (LPI) in Phase 1 Pivotal Study for Recombinant Human Natural Hyaluronidase PH20
May 26, 2025
Huonslab Announces Successful Enrollment and Administration of First Patient in Phase 1 Pivotal Study for Hydizyme™ (rHuPH20)
December 10, 2024
Research Huons Global Co., Ltd.
Huons Global Co., Ltd. company profile
View the public company page for Huons Global Co., Ltd. on 6ix.
Huons Global Co., Ltd. news
Read company news and market updates connected to Huons Global Co., Ltd..
Huons Global Co., Ltd. investor events
Find investor webinars, events, and replay context for Huons Global Co., Ltd..